Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions

Kardiologia Polska

Volumn 68, Issue 9, 2010, Pages 1015-1020

  Wróbel, Wojciech ^a   Sinkiewicz, Władysław ^a   Gordon, Marcin ^a   Woźniak Wiśniewska, Anita ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Contrast induced nephropathy; Hydration

Indexed keywords

CREATININE; IOVERSOL; ISOTONIC SOLUTION; MINERAL WATER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; HUMAN; HYDRATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 77958544374     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovascular Med, 2003; 4 (suppl. 5): S3-S9.
2. Gleeson T, O'Dwyer J, Bulugahapitiya S et al. Contrast-induced nephropathy. Br J Cardiol, 2004; 11: AIC53-AIC61.
3. Rudnick MR, Goldfarb S. Patogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med, 2003; 4: S28-S33.
4. Wayabill MM, Wyabill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorhitms for prevention. J Vasc Interv Radiol, 2001; 12: 3-9. (Pubitemid 32095670)
5. Manske CL, Sprafka JM, Strony JT et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med, 1990; 89: 615-620.
6. Rudnick MR, Goldfarb S, Wexler L. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial. Kidney Int, 1995; 47: 254-261.
7. Bartholomew BA, Harjai KJ, Dukkipati S et al. Impact of nephropathy after percutaneus coronary intervention and a method for risk stratification. Am J Cardiol, 2004; 93: 1515-1519. (Pubitemid 38749208)
8. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneus coronary intervention. Circulation, 2002; 105: 2259-2264.
9. Gruberg L, Mehran R, Dangas G et al. Acute renal failure requiring dialysis after percutaneus coronary interventions. Catheter Cardiovasc Interv, 2001; 52: 409-416. (Pubitemid 32275026)
10. Dawson P, Cosgrove D, Grainger R. Textbook of Contrast Media, Oxford 1999.
11. Goldfarb S. Contrast-induced nephropathy: risk factors, pathophysiology and prevention. Appl Radiol, 2005; 34: 287-297.
12. Finn WF. The clinical and renal consequences of contrast induced nephropathy. Nephrol Dial Transpl, 2006; 21 (suppl. 1): 2-10.
13. Mueller C. Prevention of contrast induced nephropathy with volume supplementation. Kidney Int, 2006; 69: 16-19.
14. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology, 1993; 88: 171-178. (Pubitemid 23183119)
15. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol, 2004; 15: 251-260.
16. Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA, 2004; 291: 2328-2334.
17. Brigouri C, Marenzi G. Contrast induced nephropathy: pharmacological prophylaxis. Kidney Int, 2006; 69: 30-38.
18. Stone GW, McCullough PA, Tumlin JA. CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized, controlled trial. JAMA, 2003; 290: 2284-2291. (Pubitemid 37430561)
19. Gurkowski L, MacDougall M, Wiegemann T. Effects of misoprostol on contrast-induced renal dysfunction. Am J Ther, 1995; 2: 837-842.
20. Wang A, Holcslaw T, Bshore TM. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int, 2000; 57: 1675-1680. (Pubitemid 30207926)
21. Arakawa K, Suzuki H, Naitohi M. Role of adenosine in the renal responses to contrast medium. Kidney Int, 1996; 29: 1199-1206. (Pubitemid 26167274)
22. Marenzi G, Lauri G, Campodonico J. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med, 2006; 119: 155-162. (Pubitemid 43151482)
23. Rudnick MR, Goldfarb S. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients a randomized trial. Kidney Int, 1995; 47: 254-261.
24. Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med, 2004; 2: 38.
25. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med, 2002; 291: 2328-2334.
26. Sandler CM. Contrast medium-induced renal dysfunction - is iodixanol the answer? N Engl J Med, 2003; 348: 551-553.
27. Garcia-Ruiz C, Martinez-Vea A, Sempere T et al. Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydration. Clin Nephrol, 2004; 61: 170-176. (Pubitemid 38396907)
28. Taylor AJ, Hotchkiss D, Morse RW et al. PREPARED: Preparation for Angiography in Renal Dysfunction. A randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest, 1994; 114: 1570-1574.
29. Dussol B, Morange S, Loundoun A et al. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrology Dialysis Transplant, 2006; 21: 2120-2126. (Pubitemid 44295036)
30. Trivedi HS, Moore H, Nasr S et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron, 2003; 93: C29-C34.